Table 4.
Correlations between proprotein convertase subtilisin/kexin type 9 (PCSK9) and other clinical characteristics of participants
| Variables | PCSK9 | |
| Correlation coefficient | P values | |
| Age (years) | −0.0870 | 0.19 |
| Time from CABG surgery | 0.0430 | 0.52 |
| SBP (mm Hg) | 0.0085 | 0.90 |
| DBP (mm Hg) | 0.0639 | 0.33 |
| White blood cell count (109/L) | 0.2533 | <0.01 |
| Platelet count (109/L) | 0.1235 | 0.06 |
| Red cell distribution width (%) | 0.0430 | 0.52 |
| Mean platelet volume | 0.0805 | 0.23 |
| Plateletcrit | 0.0850 | 0.20 |
| Platelet distribution width | −0.0283 | 0.67 |
| Total cholesterol (mmol/L) | 0.0461 | 0.49 |
| Triglycerides (mmol/L) | 0.1215 | 0.07 |
| HDL-C (mmol/L) | −0.0324 | 0.63 |
| LDL-C (mmol/L) | 0.0178 | 0.79 |
| VLDL (mmol/L) | 0.1772 | <0.01 |
| Lipoprotein (a) (mmol/L) | −0.0284 | 0.67 |
| Apolipoprotein A (mmol/L) | −0.0201 | 0.76 |
| Apolipoprotein B (mmol/L) | 0.0763 | 0.26 |
| Fasting glucose (mmol/L) | 0.0177 | 0.79 |
| Homocysteinaemia (μmol/L) | 0.0399 | 0.55 |
DBP, diastolic blood pressure; HDL-C, high-density lipoprotein cholesterol; LDL-C, low-density lipoprotein cholesterol; SBP, indicated systolic blood pressure; VLDL, very low-density lipoprotein.